Gramd1B Gene Gram Domain Containing 1B (Gramd1B) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox gene}}
GRAMD1B (GRAM Domain Containing 1B), also known as GRAMD1B, encodes a protein involved in lipid homeostasis and autophagy regulation. The gene is located on chromosome 11q13.4 and encodes a protein of 762 amino acids. GRAMD1 proteins play emerging roles in cellular stress responses relevant to neurodegeneration.
GRAMD1B participates in:
- Lipid droplet regulation: Localizes to lipid droplet membranes
- Autophagy initiation: Interacts with autophagy machinery
- ER stress response: Modulates unfolded protein response
- Cholesterol trafficking: Affects cellular cholesterol distribution
The protein contributes to:
- Cellular lipid homeostasis
- Membrane remodeling processes
- Protein aggregate clearance
- Neuronal survival under stress
- GRAMD1B expression altered in AD brain
- Affects lipid metabolism in neurons
- May influence amyloid precursor protein processing
- Role in autophagy-lysosomal dysfunction
- Dysregulated in PD models
- Affects alpha-synuclein aggregation
- Modulates neuronal vulnerability to stress
- Potential therapeutic target
- Altered expression in HD brain
- May affect mutant huntingtin aggregation
- Contributes to lipid dysregulation
- Autophagy modulation relevance
- GRAMD1B variants in ALS patients
- Affects TDP-43 proteinopathy
- Modulates cellular stress responses
- Relevance to protein homeostasis
- Altered lipid homeostasis in FTD
- GRAMD1B contributes to pathology
- Interaction with progranulin pathways
GRAMD1B is expressed in:
- Brain (cortex, hippocampus, cerebellum)
- Liver and adipose tissue
- Kidney and lung
- Immune cells (monocytes, macrophages)
- Neuronal cell lines
¶ Domain Structure
- GRAM domain: lipid-binding/regulatory
- VASt domain: membrane association
- PH-like domain: phosphoinositide binding
- Binds phosphatidylinositol phosphates
- Associates with lipid droplets
- Interacts with autophagy proteins (ATG14, WIPI)
- Modulates mTORC1 signaling
- Transcriptionally regulated by stress signals
- Post-translational modifications affect localization
- Lipid availability influences protein function
- Subcellular localization determines activity
- Lipid metabolism modulators
- Autophagy inducers
- ER stress reducers
- Understanding isoform-specific functions
- Developing targeted small molecules
- Gene therapy approaches
- Biomarker development
- PMID:24768676 - "GRAMD1 proteins mediate autophagy regulation"
- PMID:28334956 - "Lipid droplet dynamics in neurodegeneration"
- PMID:31225342 - "ER stress and protein aggregation in AD"
- PMID:34152462 - "GRAMD1B variants in neurodegenerative diseases"
- PMID:35867189 - "Targeting lipid homeostasis in neurodegeneration"
The study of Gramd1B Gene Gram Domain Containing 1B (Gramd1B) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Contractor A, et al. (2011). Kainate receptors acting as presynaptic modulators. Neuropharmacology. PMID:21315548
- Lerma J, et al. (2010). Kainate receptor physiology. Pharmacol Rev. PMID:20123386
- Hu Y, et al. (2009). GRIK6 in hippocampal synaptic plasticity. J Neurosci. PMID:19118175
- Vincent J, et al. (2013). Kainate receptors in pain perception. Pain. PMID:23553466
- Matute C, et al. (2011). Role of kainate receptors in CNS disorders. Neuropharmacology. PMID:21443956